MediciNova Inc.
MNOV:NASDAQ
MediciNova is a publicly-traded biopharmaceutical company founded upon developing novel, small-molecule therapeutics for the treatment of diseases with unmet medical needs with a primary commercial focus on the U.S. market.
Streetwise Company Fact Sheet2025/1/22 1:51:54
(MNOV:NASDAQ)
Analyst coverage
| Zacks Small-Cap Research — David Bautz |
| D. Boral Capital — Jason Kolbert |
| B. Riley Securities — Mayank Mamtani |
| Maxim Group — Jason McCarthy |
Streetwise Reports Articles
| 12/06/2024 - View Article |
Streetwise - MediciNova Inc. Ownership Overview*
MediciNova Inc. (MNOV:NASDAQ)
*Share Structure as of 12/6/2024
© 2025 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
